STOCKHOLDERS' DEFICIT, STOCK OPTIONS AND WARRANTS (Details Textual) (USD $)	1 Months Ended						2 Months Ended		3 Months Ended	6 Months Ended		12 Months Ended										6 Months Ended		1 Months Ended		6 Months Ended	1 Months Ended	2 Months Ended			2 Months Ended	1 Months Ended		6 Months Ended	12 Months Ended		0 Months Ended	3 Months Ended	0 Months Ended	1 Months Ended	146 Months Ended	1 Months Ended	6 Months Ended		12 Months Ended	2 Months Ended	1 Months Ended			6 Months Ended	12 Months Ended		6 Months Ended	12 Months Ended			6 Months Ended		12 Months Ended	6 Months Ended	12 Months Ended			6 Months Ended		12 Months Ended
	Mar. 31, 2014	Feb. 28, 2014	May 31, 2013	Apr. 30, 2013	Jan. 31, 2013	Nov. 30, 2012	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2014	Jun. 30, 2014	Jun. 30, 2013	Mar. 31, 2014	Dec. 31, 2009	Aug. 04, 2014	Dec. 31, 2013	Oct. 31, 2013	Sep. 11, 2013	Jan. 15, 2013	Mar. 28, 2012	Sep. 07, 2011	Jun. 22, 2010	Jun. 30, 2014 SOK Partners, LLC, [Member]	Feb. 28, 2014 Dr.Samuel Herschowitz [Member]	Jan. 31, 2014 CEO [Member]	Apr. 30, 2013 CEO [Member]	Jun. 30, 2014 CEO [Member]	Jan. 31, 2013 Private Placement [Member]	Jun. 30, 2013 Private Placement [Member]	Mar. 31, 2013 Private Placement [Member]	Mar. 15, 2013 Private Placement [Member]	Jun. 30, 2013 Private Placement 2 [Member]	Apr. 30, 2013 Consultant [Member]	Jan. 31, 2013 Consultant [Member]	Jun. 30, 2014 Warrant [Member]	Dec. 31, 2013 Warrant [Member]	Jun. 30, 2014 Warrant [Member] SOK Partners, LLC, [Member]	Mar. 15, 2013 Warrant [Member] Private Placement [Member]	Mar. 31, 2013 Warrant [Member] Private Placement [Member]	Mar. 15, 2013 Warrant [Member] Private Placement 2 [Member]	Feb. 28, 2014 Series A Convertible Preferred Stock [Member]	Jun. 30, 2014 Series A Convertible Preferred Stock [Member]	Mar. 31, 2014 Warrant Holder [Member]	Jun. 30, 2014 Warrant Holder [Member]	Jun. 30, 2014 Preferred Holder [Member]	Mar. 31, 2014 Preferred Holder [Member]	Sep. 30, 2013 Twenty Four Warrant Holders [Member]	Oct. 31, 2013 One Warrant Holder [Member]	Sep. 10, 2013 Stock Incentive Plan 2012 [Member]	Apr. 15, 2013 Stock Incentive Plan 2012 [Member]	Jun. 30, 2014 Stock Options and Warrants [Member]	Dec. 31, 2013 Stock Options and Warrants One [Member]	Dec. 31, 2013 Stock Options and Warrants Two [Member]	Jun. 30, 2014 Minimum [Member]	Dec. 31, 2013 Minimum [Member]	Sep. 30, 2013 Minimum [Member]	Sep. 10, 2013 Minimum [Member]	Jun. 30, 2014 Minimum [Member] Warrant [Member]	Jun. 30, 2014 Minimum [Member] Stock Options and Warrants [Member]	Dec. 31, 2013 Minimum [Member] Stock Options and Warrants [Member]	Jun. 30, 2014 Maximum [Member]	Dec. 31, 2013 Maximum [Member]	Sep. 30, 2013 Maximum [Member]	Sep. 10, 2013 Maximum [Member]	Jun. 30, 2014 Maximum [Member] Warrant [Member]	Jun. 30, 2014 Maximum [Member] Stock Options and Warrants [Member]	Dec. 31, 2013 Maximum [Member] Stock Options and Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted Average Remaining Life													2 years 6 months																																						5 years	10 years	2 years					5 years		6 years 6 months					10 years
Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate										0.00%																																								0.00%	0.00%
Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum																																																		59.00%
Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum																																																		66.00%
Issued - Average Exercise Price																																		$ 0.27	$ 0.12																			$ 0.119			$ 0.01	$ 0.0586			$ 0.242			$ 0.769	$ 0.1837
Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Volatility Description										The Company compiled historical volatilities over a period of 2 to 7 years of 15 small-cap medical companies traded on major exchanges and 10 mid-range medical companies on the OTC Bulletin Board and combined the results using a weighted average approach.
Amortization of debt discount								$ 275,640		$ 0	$ 92,538
Debt Instrument Convertible Remaining Discount Amortization Period 1					12 months	6 months
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate													1.37%																																													1.44%	0.78%						2.75%	2.04%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate										59.00%			63.00%																																						59.00%	66.00%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number																						31,341,741
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price										$ 0.10
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested and Expected To Vest, Outstanding, Weighted Average Remaining Contractual Term 1																						8 years 9 months 14 days
Share-based Compensation Expense											1,378,541											352,762
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized, Stock Options										259,398
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition 1										18 months
Common stock, shares authorized										800,000,000					800,000,000			300,000,000		200,000,000	80,000,000																											100,000,000	50,000,000							300,000,000							800,000,000
Debt Instrument, Face Amount						156,243																					300,000	1,000,000
Convertible Notes Converted Into Common Stock			1,116,084		2,500,000																						2,500,000	6,000,000			4,611,111
Debt Instrument, Convertible, Conversion Price				$ 0.10	$ 0.12												$ 0.014		$ 0.065								$ 0.15
Accumulated discounts on current portion of convertible debt (in dollars)					77,644					46,072					0																			23,876
Debt Instrument, Convertible, Effective Interest Rate										24.00%																	8.00%	8.00%
Shares Grants Increase For Threshold																																																	20,000,000
Shares issued under PPM to five investors at $.07 per share (in shares)																																							3,571,429
Common stock, par value (in dollars per share)			$ 0.01							$ 0.01					$ 0.01															$ 0.01
Shares Issued, Price Per Share																													$ 0.07	$ 0.07
Warrants Term																											5 years	5 years
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.325	$ 0.10				$ 0.10	$ 0.18		$ 0.325	$ 0.18					$ 0.25							$ 0.27								$ 0.198					$ 0.165	$ 0.08	$ 0.15	$ 0.15																$ 0.15							$ 0.46
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		1,600,000						444,444		1,615,383	444,444			4,615,385									111,111						7,142,857	7,142,858						407,318	7,142,858	7,142,857
Interest Payable						11,169
Stock Issued During Period, Value, New Issues																																					500,000	500,000		2,055,000	2,055,000
Stock Issued During Period, Shares, New Issues			357,163	1,041,622																																				20,550
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price																								$ 0.0167	$ 0.01	$ 0.15						$ 0.01		$ 0.13	$ 0.11												$ 0.125
Stock Issued During Period, Value, Stock Options Exercised																																														$ 1,044,490	$ 125,000
Issuance of net exercise provision shares							6,533,788
Preferred Stock Conversion Price, Per Share																																								$ 0.26
Warrants Expiration										five years
Percentage Of Additional Warrants Issued To Purchase Common Stock		30.00%
Convertible Preferred Stock, Terms of Conversion										Preferred Shares are convertible at the option of the holder into the number of shares of Common Stock determined by dividing the stated value of the Preferred Shares being converted by the conversion price of $0.26, subject to adjustment for stock splits, reverse stock splits and similar recapitalization events. If the Company issues additional shares of Common Stock, other than certain stock that is excluded under the terms of the Securities Purchase Agreement, in one or more capital raising transactions with an aggregate purchase price of at least $100,000 for a price less than the then existing conversion price for the Preferred Shares (the New Issuance Price), then the then existing conversion price shall be reduced to the New Issuance Price, provided, however, that under no circumstances shall the New Issuance Price be less than $0.13 or reduced to a price level that would be in breach of the listing rules of any stock exchange
Beneficial Ownership Limitation, Percentage										4.99%
Preferred Shareholders, Receivable, Upon Any Liquidation, Description										an amount equal to $2,055,000 times 1.2, plus all declared but unpaid dividends
Cashless Exercise Of Common Stock Warrants Total									1,158,131
Stock Issued During Period, Shares, Conversion of Convertible Securities																																												116,934	72,760
Cashless Exercise Of Common Stock Shares Issued	250,000
Conversion Of Stock Price Per Share										$ 0.26		$ 0.26
Preferred Stock, Dividend Rate, Percentage	6.00%									6.00%		6.00%
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period																								325,187	333,330							200,000	200,000	2,220,831	17,901,127							333,334	279,366			10,444,898